<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><condition>Colorectal Neoplasms</condition><condition>EGFR Inhibitor Induced Acneiform Lesions</condition><disease>Colorectal Neoplasms</disease><disease>Egfr Inhibitor Induced Acneiform Lesions</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2299887</full_dataset_link><location>United States</location><location>Israel</location><study_start_month>8</study_start_month><keyword>LUT014</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions</name><description>The purpose of this phase 1, multicenter study is to evaluate the safety, tolerability and preliminary efficacy of LUT014 in adult metastatic colorectal cancer patients with EGFR Inhibitor induced acneiform lesions</description><dates><creation>2019-08-15</creation></dates><accession>2299887</accession><cross_references><ClinicalTrials___gov>NCT03876106</ClinicalTrials___gov></cross_references></HashMap>